Researchers across a wide variety of disciplines at Penn Medicine and the Perelman School of Medicine are using their expertise to address the COVID-19 pandemic. They are conducting a number of clinical trials that are currently enrolling participants. Learn more about each clinical trial below. Visit our mRNA Vaccine Development page to learn about the science behind mRNA vaccines.
Search for non-cancer research studies and clinical trials
Search for cancer trials at Abramson Cancer Center
The ACTIV-2 Study is testing an investigational medicine to see if they are safe and can help adults with COVID-19 get better. We also want to see if this study drug is safe, can stop the disease process and prevent hospitalization.
The purpose of this study is to see how your body responds to a vaccine and how your body forms a protective response after vaccination. We are studying immune response to the yellow fever vaccine and the COVID-19 vaccines.
We are interested in comparing 3 care conditions to determine which condition is best to help people with opioid use disorder (OUD) and mental illness reduce their drug use and improve their psychiatric symptoms.
The overall purpose of the biobank is to collect and store biological specimens where available, as well as health information of people who may or may not have been exposed to the SARS-CoV-2 virus as well as those who have developed COVID-19 disease
The main purpose of this study is to try a new type of laboratory test for COVID-19 (also called SARS-CoV-2 or novel coronavirus).
The purpose of this research study is to understand how our patients with Multiple Sclerosis (MS) and other neuroimmune disorders are being affected by the COVID-19 outbreak.
This will be an observational study to investigate the feasibility and efficacy of a home-based, tech enabled, remotely supervised, cardiac rehabilitation (CR) program in qualifying American adults who cannot participate in traditional rehab.